Symposia: Lymphomas: Translational–Non-Genetic
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Hodgkin lymphoma, Biological therapies, Viral, adult, Translational Research, Lymphomas, non-Hodgkin lymphoma, B Cell lymphoma, Combination therapy, genomics, bioinformatics, blood banking, Checkpoint Inhibitor, drug development, pediatric, Diseases, indolent lymphoma, immune mechanism, cell expansion, aggressive lymphoma, Therapies, Infectious Diseases, immunology, Immunotherapy, Lymphoid Malignancies, metabolism, computational biology, Biological Processes, microbiome, emerging technologies, Monoclonal Antibody Therapy, molecular biology, Technology and Procedures, Study Population, profiling, Human, pathogenesis, imaging, omics technologies
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Hodgkin lymphoma, Biological therapies, Viral, adult, Translational Research, Lymphomas, non-Hodgkin lymphoma, B Cell lymphoma, Combination therapy, genomics, bioinformatics, blood banking, Checkpoint Inhibitor, drug development, pediatric, Diseases, indolent lymphoma, immune mechanism, cell expansion, aggressive lymphoma, Therapies, Infectious Diseases, immunology, Immunotherapy, Lymphoid Malignancies, metabolism, computational biology, Biological Processes, microbiome, emerging technologies, Monoclonal Antibody Therapy, molecular biology, Technology and Procedures, Study Population, profiling, Human, pathogenesis, imaging, omics technologies
Sunday, December 11, 2022: 12:00 PM-1:30 PM
Great Hall AD
(Ernest N. Morial Convention Center)
Moderators:
James Godfrey, MD, City of Hope
and
Anamarija M. Perry, MD, University of Michigan
Disclosures:
Godfrey: Secura Bio: Research Funding; Merck: Research Funding.
12:00 PM
12:15 PM
12:30 PM
12:45 PM
1:00 PM
1:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH